Genmab A (GMAB) Tax Rate (2024 - 2026)
Genmab A's (GMAB) quarterly Tax Rate came in at 2.71% in Q2 2026, up 2310.0% on a YoY basis from 0.11% in Q2 2025, and up 300.68% quarter-over-quarter from 1.35% in Q1 2026.
Analysis
Genmab A (GMAB) Tax Rate (2024 - 2026) Analysis & Trends
Genmab A (GMAB) has reported Tax Rate for 3 consecutive years, with 2.71% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate rose 2310.0% year-over-year to 2.71%; the trailing twelve-month figure through Jun 2026 stood at 1.46% (changed N/A YoY), and the FY2025 full-year result was 20.02%, up 546.0% from the prior year.
- Tax Rate rose to 2.71% in Q2 2026 per GMAB's latest filing, from 1.35% in the prior quarter.
- Across five years, Tax Rate topped out at 28.96% in Q2 2024 and bottomed at 20.39% in Q2 2025.
- Historically, Tax Rate has averaged 2.48% across 3 years, with a median of 0.68% in 2026.
- The sharpest annual moves came in 2025 and 2026: Tax Rate sank 4935 bps in 2025, then soared 2310 bps in 2026.
- Over 3 years, Tax Rate stood at 28.96% in 2024, then sank by 170 bps to 20.39% in 2025, then surged by 113 bps to 2.71% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 2.71%, 1.35%, and 20.39% for Q2 2026, Q1 2026, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 15.11% |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | -1.96% |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | -10.89% |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 1.34% |
| 10 | Genmab A | 2.23 Bn | 728.64 Mn | 1.07 Bn | 2.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.71% |
| Mar 31, 2026 | -1.35% |
| Jun 30, 2025 | -20.39% |
| Jun 30, 2024 | 28.96% |